This page is for clinic owners and marketing teams who produce website content, social media posts, or paid ads targeting Belgian patients. Belgium has two language communities, two professional orders running in parallel, and a near-total advertising prohibition for aesthetic medicine that catches foreign clinics completely off-guard.
Who This Page Is For
If your clinic is in Belgium, or if you are outside Belgium and running Dutch- or French-language advertising targeting Belgian patients, this guide applies. Belgian advertising rules are not the same as Dutch (Netherlands) rules or French (France) rules — even when the language is identical. Running the same campaign across Belgium and the Netherlands, or Belgium and France, without a Belgian-specific review is a compliance gap that is routinely missed.
Belgium is particularly high-risk for any clinic involved in aesthetic medicine, device-based treatments, or campaigns that involve medicine suppliers, influencers, or promotional pricing. If any of those elements are present in your marketing, this page tells you exactly where the lines are drawn.
Belgium regulates healthcare advertising through overlapping layers rather than one statute. The federal agency FAMHP enforces strict rules on medicine and medical device advertising. The two professional orders — one Dutch-language (Orde van Geneesheren), one French-language (Ordre des Médecins) — enforce deontological rules that go well beyond what advertising law alone would require. Consumer protection law sits on top as a further layer. Any single piece of content can fail on one, two, or all three tracks at once — and all three enforcement bodies can act simultaneously.
For aesthetic medicine, Belgium operates what is effectively a near-total advertising prohibition. The permitted zone is limited to factual, objective, discreet personal information: who you are, where you are, what officially recognised qualifications you hold. Before/after photos, patient testimonials, promotional pricing, outcome guarantees, and influencer-style content are all outside that permitted zone for aesthetic procedures. This is not an interpretation — it is the documented Belgian position, and it applies to foreign clinics targeting Belgian patients as much as it does to clinics based in Brussels or Ghent.
The Belgian Trigger Word List
These are the phrases most consistently flagged in Belgian compliance reviews — in both Dutch and French. Swap them out before anything else.
| What you wrote | Why it’s a problem | What to write instead |
|---|---|---|
| Résultats garantis / Gegarandeerd resultaat | Outcome guarantees are prohibited under Belgian consumer law (WER) and the Orders’ deontological codes. No treatment outcome can be guaranteed; the claim is both commercially misleading and professionally improper. | Les résultats varient — nous en discutons lors de la consultation / Resultaten variëren — we bespreken dit tijdens het gesprek |
| Sans risque / Risicovri / 100% veilig / 100% sûr | Risk-free or absolute-safety claims are prohibited as misleading efficacy claims under Belgian consumer law and Order deontological standards. Every procedure carries risk; denying it is both factually wrong and legally actionable. | Procédure réalisée avec soin — risques et alternatives discutés en consultation / Ingreep uitgevoerd met zorg — risico’s en alternatieven besproken bij afspraak |
| Avant/après (aesthetic context) / Voor/na (esthetisch) | Before/after imagery for aesthetic procedures sits squarely outside the Belgian permitted zone for aesthetic advertising. It is promotional by design and incompatible with the factual, discreet, objective standard required for aesthetic communications. | Informations sur la procédure et ce que vous pouvez réalistement attendre: [lien] / Informatie over de behandeling en realistische verwachtingen: [link] |
| Consultation gratuite (as aesthetic conversion hook) | A free consultation offered as a promotional conversion tool for aesthetic treatments is treated as a form of promotional advertising — incompatible with the Belgian aesthetic advertising framework. The free-offer mechanic creates the kind of persuasive urgency the framework is designed to prevent. | Prenez rendez-vous pour un entretien d’information / Maak een afspraak voor een informatiegesprek |
| Meilleure clinique de Bruxelles / België’s beste kliniek | Unverifiable superiority claims violate Belgian consumer law (WER unfair commercial practices) and Order deontological standards on non-sensational, objective communication. Without documented, third-party verified evidence, these claims are unlawful. | Reconnu(e) par [verified third party] / Erkend door [geverifieerde instantie] |
| Promo / Offre spéciale / Speciale aanbieding (for medical/aesthetic treatments) | Promotional pricing mechanics and special offers for medical or aesthetic procedures are incompatible with the Belgian requirement for factual, non-sensational, non-persuasive healthcare communication. For aesthetic procedures, they are effectively prohibited. | Nos tarifs sont disponibles sur notre site / Onze tarieven vindt u op onze website |
| Botox / Botox® (in public promotional context) | Botox is a prescription product. Public advertising of prescription medicines is prohibited under Belgian medicines law (Law of 25 March 1964). This applies to clinics, their social media accounts, and any influencers or third-party publishers they use. | Traitement à la toxine botulique — évaluation médicale préalable requise / Botulinum-toxinebehandeling — medische beoordeling vereist |
| Patiënte X recommande / Patient X geeft aan: “…” | Patient testimonials used as persuasion or conversion tools are high-risk in standard Belgian medical advertising and effectively prohibited in the aesthetic context. They raise issues of verifiability, selective presentation, medical secrecy, and undue influence on vulnerable patients. | Pour en savoir plus sur nos traitements: [lien] / Meer informatie over onze behandelingen: [link] |
| Révolutionnaire / Innovant sans précédent / Revolutionair | Inflated product or technology claims are misleading and incompatible with the objective, evidence-based communication standard required by Belgian Order deontological codes and consumer law. All such claims require verified, current scientific substantiation. | Traitement réalisé selon les standards actuels / Behandeling volgens actuele standaard |
| Code promo / Kortingscode (for clinical treatments) | Discount codes for clinical or aesthetic treatments combine price-pressure, promotional mechanics, and possible influencer disclosure issues simultaneously. In Belgium, this format is incompatible with healthcare advertising standards across all relevant layers — Order, consumer law, and FAMHP (if a prescription product is named). | Contactez la clinique directement pour les tarifs / Neem rechtstreeks contact op met de kliniek voor tarieven |
5 Real-World Rewrites — Before & After
Each example uses real Belgian clinic marketing patterns. The rewrites reflect both the Dutch-language and French-language versions where both are relevant.
Problems: outcome guarantee (“gegarandeerd pijnloos”) is prohibited under WER and Order deontological standards; unverifiable superlative (“beste tandkliniek van Brussel”) violates WER unfair commercial practices; “gratis raadpleging deze maand” is a promotional conversion mechanic — incompatible with Belgian healthcare advertising standards.
Why it’s lower risk: no outcome guarantee, no unverifiable superlative, free consultation mechanic removed, pricing deferred to consultation. Neutral, factual, and aligned with Belgian consumer law and Order deontological standards.
Problems: outcome guarantee prohibited; before/after photos for aesthetic procedures are outside the Belgian permitted advertising zone; unverified promotional statistic; free consultation with deadline = promotional urgency mechanic incompatible with aesthetic advertising framework. This single post hits multiple hard limits simultaneously.
Why it’s lower risk: no before/after, no guarantee, no urgency mechanic, no unverified statistic. Consultation framing stays within the factual, objective, discreet standard required for Belgian aesthetic communication.
Problems: “Botox” is a prescription product — public advertising prohibited under Law of 25 March 1964; “sans risque” = prohibited risk-free claim; promotional bundle pricing for aesthetic treatments = outside permitted Belgian advertising zone; before/after for aesthetic procedures = effectively prohibited; Instagram stories = unlawful public promotion of a prescription product.
Why it’s lower risk: generic product name (not the brand), no risk-free claim, no promotional pricing, no before/after. Consultation framing with individual results qualifier addresses both the WER misleading claims risk and the Order’s unjustified-expectations standard.
Problems: “révolutionnaire” is an inflated, unsubstantiated technology claim prohibited under WER and Order standards; patient testimonial used as promotional driver is high-risk in Belgian clinic context and effectively prohibited in aesthetic context; promotional discount on aesthetic treatment is outside the permitted Belgian advertising zone.
Why it’s lower risk: no testimonial, no inflated product claim, no promotional discount, individual results framing. Factual, non-sensational, and aligned with the Belgian standard for clinical communication.
Problems: no commercial disclosure violates WER (unfair commercial practices — hidden advertising); “Botox” named = unlawful public promotion of a prescription product via influencer (FAMHP enforces this on third parties); before/after for aesthetic procedure = outside permitted zone; promotional discount code for aesthetic treatment = outside permitted zone. The clinic is co-responsible for content it facilitates.
Why it’s lower risk: commercial relationship disclosed at the start, no prescription product named, no before/after, no discount code. Clinic should brief influencer partners explicitly and retain a written copy of the brief — the clinic bears responsibility for facilitating unlawful content.
High-Risk Content — What Belgian Rules Actually Prohibit
These are not grey areas — each is a confirmed prohibition or effective prohibition under Belgian medical advertising law as documented by FAMHP and the Orders of Physicians.
The risk: Belgium’s position on aesthetic medicine advertising is the strictest in this country set. Only factual, objective, relevant, verifiable, discreet, and clear personal information is permitted — who the doctor is, where they practise, what official qualifications they hold. The moment content becomes promotional, persuasive, or outcome-oriented, it leaves the permitted zone. This covers your website, social media, paid ads, and influencer content equally.
In practice: Before/after photo galleries on clinic websites, Instagram reels showing aesthetic results, promotional packages for rhinoplasty or lip fillers, “transformation” messaging, aesthetic outcome testimonials, discount campaigns for any cosmetic procedure.
The risk: Before/after imagery for aesthetic treatments is incompatible with Belgian aesthetic advertising rules. It is promotional by design — its function is to persuade prospective patients by showing outcomes, which is exactly what the Belgian framework does not permit. Even if images are real, unmanipulated, and the patient has given consent, using them in consumer-facing aesthetic marketing is outside the permitted zone.
In practice: Before/after galleries for rhinoplasty, lip fillers, Botox, blepharoplasty, breast augmentation, body contouring — on any channel, in any format.
The risk: Public advertising of prescription-only medicines is prohibited under the Law of 25 March 1964 on medicines, enforced by FAMHP. This applies to clinics advertising injectable treatments (Botox, prescription dermal fillers), influencers promoting those treatments, and any third-party publisher who places the content. FAMHP enforces this both offline and online, and can act against publishers and platforms, not only the originating clinic.
In practice: Social posts promoting “Botox” by name with pricing or efficacy claims, sponsored content featuring injectable aesthetic results, discount codes for prescription injectable treatments via influencer channels.
The risk: It is prohibited to promise, offer, or grant premiums, monetary advantages, or benefits in kind to persons qualified to prescribe, dispense, or administer medicinal products. This rule has been extended to medical devices and accessories. If your clinic receives benefits from a device or medicine supplier — directly or indirectly — the arrangement requires careful legal review. Scientific events involving at least one overnight stay require prior Mdeon visa approval. FAMHP published new enforcement guidelines on this in May 2026 — active enforcement is explicitly elevated.
In practice: Supplier-funded hospitality dinners, medical conference travel covered by a device manufacturer, branded “educational” events with commercial purpose, gifts or samples beyond narrow statutory exceptions.
The risk: Belgium’s enforcement model is deliberately multi-track. The same campaign can simultaneously trigger FAMHP administrative action (medicine/device advertising), Order of Physicians disciplinary proceedings (professional ethics), and consumer law enforcement (WER unfair commercial practices). A clinic that focuses only on “advertising law” review can still be hit on professional discipline grounds. The Order can act ex officio — not only on complaint. And from April 2026, Belgian authorities are under active scrutiny for cross-border enforcement cooperation.
In practice: Any campaign that has been reviewed only by a marketing or consumer-law adviser without a medical ethics and FAMHP-specific check leaves two out of three enforcement tracks unreviewed.
The risk: Guaranteeing treatment outcomes and claiming that procedures are risk-free are prohibited across all levels of Belgian medical advertising law — consumer law, deontological codes, and medicines regulations. These are also inconsistent with the pre-treatment information obligations that require clinicians to discuss real risks and realistic outcomes before any treatment decision.
In practice: “Résultats garantis,” “gegarandeerd resultaat,” “sans risque,” “risicovri,” “100% sûr,” “altijd pijnloos.”
The Grey Areas — Allowed Under Specific Conditions
Not outright banned — but require careful framing and, in several cases, legal pre-clearance before publication.
Allowed if: Complete, current, factual price list published as patient information. Transparent, non-sensational, framed as a service information resource rather than a conversion tool. Full pricing presented — not “from €X” hooks.
Crosses the line if: Promotional pricing, “today only” framing, bundled aesthetic offers, or any time-limited price mechanic. For aesthetic procedures: any pricing framing that functions as a sales incentive rather than neutral patient information is outside the permitted zone.
Allowed if: Authentic, unsolicited review passively displayed on a third-party platform (Google, Doctena, etc.) without active editorial curation by the clinic. The clinic should not selectively feature, amplify, or use individual reviews as conversion tools in its own marketing.
Crosses the line if: Testimonials actively featured on the clinic’s own website or social media as promotional content; selectively curated; used in any aesthetic advertising context; involve medical secrecy (content reveals diagnosis or treatment details); patient consent not documented for any identifiable personal data use.
Allowed if: Factual description of technology or equipment used: “uses laser technology,” “offers MRI-guided diagnostics,” “equipped with [device name].” The description is accurate and not comparative.
Crosses the line if: Comparative, outcome-based, or superiority claims: “safer than conventional methods,” “painless and scar-free,” “clinically superior,” “revolutionary.” Once the message attributes an outcome or advantage to the technology, substantiation requirements and device-regulatory review apply under MDR.
Allowed if: Commercial relationship disclosed at the start (#Publicité / #Reclame). No prescription product named. No before/after content. No promotional mechanics (discount codes, time-limited offers). Content stays within the same factual, objective standard required of the clinic itself. No aesthetic outcome claims.
Crosses the line if: Any of the above conditions are missing. The clinic is co-responsible for content it facilitates — FAMHP and WER enforcement can reach the originating clinic regardless of which account published the post.
Allowed if: Dutch and French versions of all content are substantively identical — not merely translated. Both the Orde van Geneesheren (Dutch/Flanders) and the Ordre des Médecins (French/Wallonia+Brussels) apply to any national Belgian campaign. The two Orders have not been confirmed to have materially different advertising standards — apply the stricter reading where in doubt.
Crosses the line if: The French and Dutch versions contain different claims, different pricing, or different levels of promotional content. Bilingual campaigns that exploit perceived differences between the two Orders are a recognised compliance risk.
The Cross-Border Trap for CEE and EU Clinics
⚠ If your clinic is outside Belgium and targeting Belgian patients — read this
Belgian consumer law (WER) applies when your advertising targets Belgian consumers — regardless of where your clinic is located. If your ads are in Dutch or French, your pages carry Belgian pricing, or your social campaigns are geo-targeted to Belgium, Belgian unfair commercial practices rules apply. Crucially, Belgian Dutch-language rules are not the same as Dutch (Netherlands) rules — running the same campaign across Belgium and the Netherlands without a Belgian-specific review is a systematic compliance gap that affects almost every CEE clinic operating in the Dutch language.
For aesthetic advertising, Belgian rules apply to foreign clinics just as directly as to Belgian ones. The effective prohibition on before/after photos, testimonials, and promotional pricing is not limited by clinic location — it is determined by the market being targeted. FAMHP medicines advertising rules likewise apply to anyone advertising prescription products to Belgian consumers, including influencers and third-party publishers working on behalf of the clinic.
The Legal Framework — For Reference
For those who want the statutory and regulatory structure behind the practical rules above.
| Law / Code | What it covers | Enforcing authority | Max penalty |
|---|---|---|---|
| Law of 25 March 1964 on medicines (as amended) + Royal Decree 7 April 1995 | Public advertising of prescription medicines prohibited; HCP advertising rules (SmPC 50% surface rule); anti-inducement provisions (Art. 10); prior approval/notification requirements for radio/TV and other media | FAMHP / FAGG — Directorate-General Inspection | Criminal / administrative sanctions — exact amounts require verification from current primary text |
| Law of 27 April 2005 (extension of anti-inducement to medical devices) | Anti-inducement prohibition extended to medical devices and accessories — same architecture as medicines anti-inducement | FAMHP | As above |
| Code of Medical Ethics — Orde van Geneesheren / Ordre des Médecins | Deontological standards for all physician advertising: factual, objective, non-promotional, non-sensational. For aesthetic medicine: effectively only factual personal information permitted. | Orde van Geneesheren (Dutch/Flanders) + Ordre des Médecins (French/Wallonia+Brussels) — provincial councils, can act ex officio | Warning → censure → reprimand → suspension up to 2 years → striking off from register |
| WER / Code of Economic Law (unfair commercial practices) | Misleading acts and omissions, blacklisted commercial practices, unverifiable superiority claims, hidden advertising, fear-based or vulnerability-exploiting messaging | SPF Économie / FOD Economie; civil courts | Criminal / administrative — exact amounts require verification from current primary text |
| Mdeon Protocol (scientific events) | Prior visa approval required for scientific events involving at least one overnight stay where medicine/device suppliers are involved | Mdeon (self-regulatory; FAMHP oversight) | Failure to obtain prior visa = underlying anti-inducement violation under Law of 25 March 1964 Art. 10 |
| Belgian Aesthetic Medicine Framework (consolidated text: UNVERIFIED from eJustice primary source) | Near-total advertising prohibition for aesthetic and cosmetic procedures — only factual, objective, discreet, verifiable personal information permitted | Orders of Physicians + civil courts | Order disciplinary sanctions (as above) + civil enforcement |
Enforcement cases and trend
No specific Order of Physicians or JEP rulings were confirmed from primary sources in our Belgium research run — this is an explicit limitation of the available research material and the gap is marked as UNVERIFIED. What is confirmed from FAMHP official sources: the Directorate-General Inspection receives and centralises complaints about advertising of medicines and health products via a dedicated contact point (famhp.be/en/complaints). FAMHP published new anti-inducement guidelines in May 2026, explicitly signalling elevated enforcement attention on supplier-funded events and hospitality arrangements.
The structural enforcement trend from 2020 to 2026 is consistent: FAMHP is becoming more administratively precise (separate document filing requirements, formal notification pathways), medicine and device advertising is under increasingly active monitoring both offline and online, and cross-border enforcement cooperation via IMI was the subject of a Belgium-specific investigation opened in April 2026. The practical risk is not only fines — it is the combination of professional-discipline exposure, Order disciplinary proceedings, FAMHP administrative action, and potential civil injunction risk, all triggered simultaneously by the same piece of content.
Legal disclaimer: This page provides general information about Belgian medical advertising regulations for educational purposes only and does not constitute legal advice. Regulations change. Some statutory penalty amounts and consolidated texts were not directly verified from primary eJustice sources at the time of writing — verify all compliance requirements with a qualified Belgian legal professional before publishing any marketing materials. MedicalServiceFinder.com accepts no liability for decisions made based on this content.
Last updated: June 2026 | Primary sources: FAMHP (famhp.be/en/human_use/medicines/medicines/proper_use/Advertising-premiums-advantages-samples), Belgium.be federal portal (belgium.be/en/about_belgium/government/federal_authorities), FAMHP complaints (famhp.be/en/complaints)
